Baystreet Staff - Friday, April 17, 2015 Akebia Therapeutics (AKBA) down on pricing new shares Akebia Therapeutics Inc (NASDAQ: AKBA) slipped 5.4% to $8.20 after the company priced 7,272,727 shares at $8.25 per share. Share volume was one million, towering over an all-day average of 32,000